Treatment of Cystic Acne Lesions

Immediate Management of the Individual Cystic Lesion

The American Academy of Dermatology recommends injecting intralesional triamcinolone acetonide 2.5-10 mg/mL directly into the cystic lesion to provide rapid pain relief and reduce inflammation within 48-72 hours, particularly for larger nodules at risk of scarring 1, 2, 3
This adjunctive treatment addresses the immediate concern while systemic therapy takes effect over subsequent weeks, as recommended by the American Academy of Dermatology 1

The American Academy of Dermatology recommends initiating triple therapy: oral doxycycline 100 mg daily + topical retinoid (adapalene 0.1-0.3% or tretinoin 0.025-0.1%) + benzoyl peroxide 2.5-5% as the foundation regimen, with moderate certainty evidence 1, 2, 4
Doxycycline is strongly recommended with moderate certainty evidence as first-line systemic antibiotic therapy by the American Academy of Dermatology 1, 2
The American Academy of Dermatology recommends limiting oral antibiotics to 3-4 months maximum to minimize bacterial resistance development 1, 2, 4
The American Academy of Dermatology always recommends using benzoyl peroxide concurrently with oral antibiotics to prevent antibiotic resistance 1, 2, 5

The American Academy of Dermatology recommends isotretinoin as the definitive treatment for severe nodular acne, treatment-resistant moderate acne after 3-4 months of appropriate therapy, or any acne with scarring or significant psychosocial burden 1, 2
Standard dosing is 0.5-1.0 mg/kg/day targeting cumulative dose of 120-150 mg/kg, with daily dosing preferred over intermittent dosing, as recommended by the American Academy of Dermatology 1, 2, 4
The American Academy of Dermatology recommends monitoring only liver function tests and lipids—CBC monitoring is not needed in healthy patients 1, 2
Mandatory pregnancy prevention through iPledge program is required for persons of childbearing potential, as recommended by the American Academy of Dermatology 1, 2

The American Academy of Dermatology recommends endocrinologic testing for females presenting with clinical signs of hyperandrogenism including infrequent menses, hirsutism, androgenic alopecia, infertility, or truncal obesity 1, 5, 6
PCOS diagnosis in adult females requires 2 of 3 criteria: androgen excess (clinical or biochemical), ovulatory dysfunction, or polycystic ovaries on ultrasonography, as defined by the American Academy of Dermatology 5, 6
A typical hormone-screening panel includes: free and total testosterone, DHEA-S, androstenedione, LH, and FSH, as recommended by the American Academy of Dermatology 5, 6

The American Academy of Dermatology recommends spironolactone 25-200 mg daily for hormonal acne patterns, premenstrual flares, or those who cannot tolerate oral antibiotics 1, 2, 3
No potassium monitoring is needed in healthy patients without risk factors for hyperkalemia, as stated by the American Academy of Dermatology 1, 2

The American Academy of Dermatology recommends never using topical or oral antibiotics as monotherapy—resistance develops rapidly without concurrent benzoyl peroxide 1, 2, 5, 6
The American Academy of Dermatology recommends never extending oral antibiotics beyond 3-4 months without re-evaluation, as this dramatically increases resistance risk 1, 2, 4

The American Academy of Dermatology recommends continuing topical retinoid monotherapy indefinitely after achieving clearance to prevent recurrence 2, 3, 4